|
|
|
|
|
by BWStearns
3340 days ago
|
|
> As with all things though, 95% success with viral excision via CRISPR, in conjunction with 95% success via immunotherapy [2], and 95% from standard anti-retrovirals [3], get's you pretty good 99.9999% coverage. I wonder if several narrow CRISPR payloads simultaneously would achieve the same effect since any survivors would need n many mutations simultaneously. |
|